“Expansion of Mobile Health and Decentralized Diagnostic Solutions”
- A key and accelerating trend in the MEA point-of-care diagnostics market is the widespread deployment of mobile health (mHealth) platforms and portable diagnostic devices aimed at decentralizing healthcare delivery. This trend is reshaping healthcare access by bringing diagnostics closer to patients, especially in rural and resource-limited settings
- For instance, m-PIMA HIV-1/2 VL by Abbott and the Cepheid GeneXpert platforms are being increasingly deployed across African countries such as Nigeria and Kenya through public health partnerships to deliver rapid results in the diagnosis of HIV, tuberculosis, and other infectious diseases
- Point-of-care solutions are being integrated with cloud-based health data systems, enabling healthcare providers to monitor and report cases in real-time. These digital integrations support national disease surveillance programs and ensure better treatment continuity. Devices such as LumiraDx and SD Biosensor are gaining traction for their portability, speed, and compatibility with mobile devices
- The rising penetration of smartphones and cellular networks in the region is driving innovation in connected diagnostic platforms that can transmit test results instantly to central systems for remote evaluation. This feature is particularly impactful in remote regions lacking fully equipped medical laboratories
- In addition, governments and NGOs across MEA are supporting this trend through initiatives that fund community health workers and equip them with mobile diagnostic kits to deliver frontline healthcare services
- This shift toward portable, connected, and rapid diagnostics is redefining the healthcare delivery model in the region, enabling more timely diagnosis and treatment and fostering growth in the point-of-care diagnostics market across both public and private health sectors
